BIO BIO-RAD LABORATORIES, INC.
Company Analysis
Latest News
Bio-Rad's third quarter 2026 revenue and earnings beat expectations behind strong PCR instrument demand
Bio-Rad Laboratories reported third quarter 2026 results that exceeded analyst estimates on both the top and bottom lines. While the Life Science segment...
Bio-Rad Laboratories Inc Q3 2026 Earnings Preview: What Analysts Expect on November 04, 2026
Bio-Rad Laboratories is expected to report third-quarter 2026 revenue of approximately $649.94 million and earnings per share of $2.61, as the stock trades at...
First Eagle Doubles Stake in Bio-Rad Labs (BIO) to $1.53B
In a recent SEC disclosure, First Eagle Investment Management revealed it has doubled its position in life sciences and diagnostics company Bio-Rad...
Mason Hawkins' Southeastern liquidates $45 million stake in Bio-Rad Labs
Value investor Mason Hawkins and his firm, Southeastern Asset Management, exited their position in Bio-Rad Laboratories during the second quarter of 2026....
Bio-Rad draws Elliott stake, targeting its 33% Sartorius holding
Elliott Management has built a significant position in life-science tools supplier Bio-Rad Laboratories. The activist investor has not yet disclosed the exact...